---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-22-017185"
form_type: "8-K"
ticker: "PAHC"
cik: "0001069899"
company_name: "PHIBRO ANIMAL HEALTH CORP"
filed_at: "2022-11-09T23:59:59+00:00"
generated_at: "2026-06-22T00:34:35.673974+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Phibro Q1 net income down 41% to $3.9M; lowers FY2023 EPS guidance due to rates, tax

## Summary
- Q1 net sales $232.5M (+8% YoY); diluted EPS $0.10 (-41%); adjusted diluted EPS $0.21 (-18%).
- Animal Health segment sales $154.9M (+10%); Mineral Nutrition $59.6M (+10%).
- FY2023 guidance: net sales $960M-$1B and adjusted EBITDA $113-$118M (unchanged).
- FY2023 diluted EPS guidance cut to $0.96-$1.06 from $1.11-$1.21; adjusted EPS to $1.21-$1.31 from $1.28-$1.38.
- Adjusted effective tax rate guidance raised to 33% from 30% due to foreign tax credit regulations.

## SEC filing metadata
- accession: 0001558370-22-017185
- form_type: 8-K
- ticker: PAHC
- cik: 0001069899
- company_name: PHIBRO ANIMAL HEALTH CORP
- filed_at: 2022-11-09T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1069899/000155837022017185/0001558370-22-017185-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1069899/000155837022017185/pahc-20221109x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-22-017185
- JSON: https://secwatch.observer/filing/0001558370-22-017185.json
- Plain text: https://secwatch.observer/filing/0001558370-22-017185.txt

## Key facts
- Earnings Releases
  PHIBRO ANIMAL HEALTH CORP reported first quarter ended September 30, 2022 results: revenue $232.5 million, net income $3.9 million, EPS $0.10.
  - Period: first quarter ended September 30, 2022
  - Revenue: $232.5 million
  - Net income: $3.9 million
  - EPS: $0.10
  - Result: reported results
  source text: tax rate for the year ending June 30, 2023. ​ Highlights for the three months ended September 30, 2022 (compared to the three months ended September 30, 2021) ​ - Net sales of $232.5 million, an increase of $17.9 million, or 8% - Net income of $3.9 million, a decrease of $2.7 million, or 41% - Diluted EPS of $0.10, a decrease of $0.07, or 41% - Adjusted EBITDA of
  evidence_url: https://www.sec.gov/Archives/edgar/data/1069899/000155837022017185/0001558370-22-017185-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.